Učitavanje...

Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) as secondline therapy for patients with advanced urothelial cancer

There is currently no standard treatment for metastatic urothelial cancer after failure of cisplatin-based therapy. The present retrospective study investigated the efficacy and safety of oxaliplatin plus 5-fluorouracil (5-FU) and leucovorin (LV) (FOLFOX) in locally advanced or metastatic urothelial...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Zhang, Sheng, Xue, Hongxi, Chen, Qiang
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295454/
https://ncbi.nlm.nih.gov/pubmed/27409828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10463
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!